secwatch.observer — SEC 8-K summary
======================================

Issuer:     Allarity Therapeutics, Inc. (ALLR)
CIK:        0001860657
Form:       8-K
Filed at:   2023-11-17T23:59:59+00:00
Accession:  0001213900-23-088375
Event type: regulatory
Sentiment:  negative
Materiality: 0.85
Item codes: 3.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Allarity Therapeutics faces Nasdaq delisting due to negative equity and bid price deficiency
--------------------------------------------------------------------------------

- Stockholders' equity as of Sep 30, 2023 was negative $3.379M, below Nasdaq's $2.5M minimum.
- Bid price has been below $1 per share for 30+ consecutive days, triggering a separate delisting notice.
- Hearing before Nasdaq Panel scheduled for Feb 1, 2024 to appeal both deficiencies.
- Company was previously under a Mandatory Panel Monitor until July 2024 for equity compliance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1860657/000121390023088375/0001213900-23-088375-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1860657/000121390023088375/ea188641-8k_allarity.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-088375

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer